Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 7/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | ESR1 | P03372 | 2/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | ELANE | P08246 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | BCL9 | O00512 | 1/20 | 0.40 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.40 |
| ▸ | CASP3 | P42574 | 1/20 | 0.39 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.39 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.39 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10768902 | 0.91 | KMT2A (0.49) | KMT2ALMNAALDH1A1MAPTHTT | |
| SCHEMBL9792720 | 0.91 | KMT2A (0.45) | KMT2ALMNAALDH1A1MAPTHTT | |
| SCHEMBL11556226 | 0.89 | KMT2A (0.44) | KMT2ALMNAALDH1A1MAPTHTT | |
| SCHEMBL4645765 | 0.89 | GAA (0.56) | KMT2ALMNAALDH1A1MAPTHTT | |
| SCHEMBL10500407 | 0.89 | LMNA (0.57) | KMT2ALMNAALDH1A1MAPTHTT | |
| SCHEMBL4643998 | 0.89 | MGLL (0.46) | KMT2ALMNAALDH1A1MAPTHTT | |
| SCHEMBL10499664 | 0.89 | KMT2A (0.44) | KMT2ALMNAALDH1A1MAPTHTT | |
| SCHEMBL137047 | 0.88 | CYP19A1 (0.52) | KMT2ALMNAALDH1A1MAPTHTT | |
| SCHEMBL6458347 | 0.87 | GSK3B (0.55) | KMT2ALMNAALDH1A1MAPTHTT | |
| SCHEMBL11147697 | 0.87 | NPSR1 (0.47) | KMT2ALMNAALDH1A1MAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8802147-B2 | Controlled release of biologically active compounds | BEZWADA BIOMEDICAL, LLC (US) | 2014-08-12 | — | — | US | disclosed |
| US-8802147-B2 | Controlled release of biologically active compounds | BEZWADA BIOMEDICAL, LLC (US) | 2014-08-12 | — | — | US | disclosed |
| US-8802147-B2 | Controlled release of biologically active compounds | BEZWADA BIOMEDICAL, LLC (US) | 2014-08-12 | — | — | US | disclosed |
| US-20140099370-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | BEZWADA BIOMEDICAL, LLC (US) | 2014-04-10 | — | — | US | disclosed |
| US-8552139-B2 | Controlled release of biologically active compounds | BEZWADA BIOMEDICAL LLC (US) | 2013-10-08 | — | — | US | disclosed |
| US-8552139-B2 | Controlled release of biologically active compounds | BEZWADA BIOMEDICAL LLC (US) | 2013-10-08 | — | — | US | disclosed |
| US-8552139-B2 | Controlled release of biologically active compounds | BEZWADA BIOMEDICAL LLC (US) | 2013-10-08 | — | — | US | disclosed |
| US-20130142752-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | BEZWADA BIOMEDICAL, LLC (US) | 2013-06-06 | — | — | US | disclosed |
| US-20130142752-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | BEZWADA BIOMEDICAL, LLC (US) | 2013-06-06 | — | — | US | disclosed |
| US-20130142752-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | BEZWADA BIOMEDICAL, LLC (US) | 2013-06-06 | — | — | US | disclosed |
| US-8217134-B2 | Controlled release of biologically active compounds | BEZWADA BIOMEDICAL, LLC (US) | 2012-07-10 | — | — | US | disclosed |
| US-8217134-B2 | Controlled release of biologically active compounds | BEZWADA BIOMEDICAL, LLC (US) | 2012-07-10 | — | — | US | disclosed |
| US-8217134-B2 | Controlled release of biologically active compounds | BEZWADA BIOMEDICAL, LLC (US) | 2012-07-10 | — | — | US | disclosed |
| US-20090060979-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | BEZWADA BIOMEDICAL, LLC | 2009-03-05 | — | — | US | disclosed |
| US-20090060979-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | BEZWADA BIOMEDICAL, LLC | 2009-03-05 | — | — | US | disclosed |
| US-20090060979-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | BEZWADA BIOMEDICAL, LLC | 2009-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130142752-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | GUSB, BMP2, APEH | KMT2A 4078/4885LMNA 2670/4885ALDH1A1 1816/4885 |
| US-20090060979-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | GUSB, BMP2, APEH | KMT2A 4078/4885LMNA 2670/4885ALDH1A1 1816/4885 |
| US-20140099370-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | GUSB, BMP2, APEH | KMT2A 4078/4885LMNA 2670/4885ALDH1A1 1816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.